Sanofi to Purchase U.S.-Based Principia Biopharma for $3.68 Billion
Sanofi will acquire all of the outstanding shares of Principia biopharma for $100 per share in cash, a price that represents an aggregate equity value of approximately $3.68 billion on a completely diluted basis.
